A concentrated sell-off in AI-driven chipmakers slammed the Nasdaq on July 16, even as strong earnings from healthcare and freight companies boosted over 75% of S&P 500 stocks. The divergence underscores a market rotation that threatens index-level returns while creating pockets of opportunity in undervalued sectors. Rising oil prices add a macro risk that could further pressure tech valuations.
Source: thetimes-tribune.com · advocate-news.com
A dual shock hit markets Monday: oil soared on a Strait of Hormuz blockade while AI chip stocks plunged. Brent jumped 7.8% to $81.92, the S&P 500 fell 0.7%, and South Korea’s Kospi cratered 8.9%.
The financial fallout from renewed U.S.-Iran hostilities hits high-growth equities hardest: South Korea’s Kospi collapses 9%, SK Hynix crashes post-IPO, and U.S. futures point to broad risk-off positioning.
SK Hynix’s record $26.5 billion IPO and a 4% Nvidia surge drove equities higher, but oil price whipsaws after Iran attacks injected caution just as earnings season begins. The cross-currents set up a pivotal stretch for investors weighing AI valuations against geopolitical risk and the Delta demand signal.
Technology stocks outperformed in a bifurcated market as SK Hynix’s Wall Street debut and buy-the-dip activity drove a 1.74% Nasdaq gain. Meanwhile, a geopolitical shock sent oil above $76/barrel and the 10-year yield toward 4.60%, punishing small caps.
Source: Panos Mourdoukoutas (us) · Panos Mourdoukoutas (us)
The Dow Jones Industrial Average briefly plummeted 800 points and the S&P 500 fell as much as 1.1% after President Trump declared the Iran ceasefire over. Markets partially recovered after Trump clarified no return to full-scale war, but the episode rattled investor confidence and reignited inflation fears.
Markets steadied on July 9 as the S&P 500 rebounded 0.8% and Brent crude slid 2.2% after President Trump’s ambiguous comments on the U.S.-Iran conflict. The price action highlights how geopolitical risk and oil supply fears are driving equity and commodity swings, with potential knock-on effects for Fed rate policy.
Source: timesfreepress.com · reflector.com
Eos Energy’s shares dropped 6.32% to $4.74 on July 7, accompanied by trading volume of 54.4 million—nearly 2x the 3-month average. The decline came despite positive project news and aligns with a sell-off across energy storage peers, with Fluence down 9.1% and Stem down 7.8%.
The Nasdaq tumbled 1.16% and the PHLX Semiconductor Index plunged 4.65% as Samsung’s earnings failed to impress overbought investors, triggering a rotation out of AI chip stocks. With Micron down 4.7% and Sandisk off 7.3%, the selloff raises fresh questions about stretched valuations. Upcoming SK Hynix listing will test whether global demand for AI hardware shares has peaked.
U.S. stocks sold off Tuesday as the Nasdaq tumbled 1.16% while the Dow edged down just 0.25%. The session highlighted a sharp rotation out of megacap technology into traditional industrial and financial names, raising questions about the durability of the bull market.
Source: newjerseytelegraph.com · asiabulletin.com
A trio of biotech stocks generated staggering H1 2026 returns, with Revolution Medicines leading at +230%. Axsome Therapeutics' revenue more than doubled to $617.1 million, underscoring a market rotation into catalyst-driven, high-growth healthcare plays amid macro uncertainty.
AI semiconductor stocks staged a powerful rebound on July 6, with Broadcom up 5.3% and Micron +4.2%, ahead of SK Hynix’s $28 billion Nasdaq IPO. TeraWulf soared 16.9% on a $19 billion data center deal with Anthropic, highlighting the capital intensity and volatility driving the AI trade.
Source: thetimes-tribune.com · broomfieldenterprise.com
Nvidia's forward P/E has collapsed to 21.7, in line with the S&P 500, while Meta's $70B+ capex narrative obscures accelerating ad revenue. This deep-value setup in AI leaders could spark a sharp re-rating as H2 earnings season kicks off.
Source: The Motley Fool · finance.yahoo.com
The Dow Jones Industrial Average set a new record at 52,900.07, while softer-than-expected US jobs data quelled rate-hike anxiety. Asian markets surged on the news, with the Kospi bouncing 2.8% from a steep selloff, as oil prices below pre-Iran-war levels bolstered the disinflation narrative.
Defying a Middle East war and rate-hike fears, the S&P 500 and Nasdaq posted their biggest quarterly gains since 2020, with the tech-heavy Nasdaq leaping 21%. Strong corporate earnings and US economic resilience drove the rally, but oil-driven inflation concerns and a stalled ceasefire could test the momentum in the second half.
Source: Straitstimes · SECTIONS US stocks today S; P ; Nasdaq post best quarter since
With the S&P 500 yielding only 1.25%, savvy income investors are turning to stocks like AT&T (4.8% yield) and Coca-Cola (64 consecutive years of dividend increases). Allocating $3,000 across these names can generate dependable quarterly income while offering capital appreciation potential.
Source: The Motley Fool · Neil Patel (us)
The Roundhill Magnificent Seven ETF has rocketed 163% since its 2023 launch, powered by Nvidia’s 16,930% decade gain. For finance pros, the equal-weight structure offers concentrated AI exposure with sharp drawdowns, raising the stakes on portfolio allocation.
Source: The Motley Fool · Neil Patel (us)
As US big tech wobbles, European investors seeking AI exposure are rotating into power suppliers and banks, capitalizing on massive EU and German fiscal packages. Prysmian surged 150% and ABB 84% on infrastructure demand, while the Stoxx 600’s minuscule 9% tech weighting forces creative ‘pick and shovel’ trades.
Source: The Business Times · Bloomberg
Despite nearly 66% of S&P 500 stocks climbing, the index posted its second losing week in 13 as heavy selling in AI megacaps like Micron completely negated the broad market rally. Oil prices dropped to pre-Iran crisis levels, boosting transportation and healthcare stocks, while Eli Lilly soared 7.1% on European drug approvals.
With a 6.9% yield (vs 1% for the S&P 500) and a 130% payout ratio, Pfizer presents a classic risk-reward scenario for income portfolios. The stock’s 60% decline from 2021 highs prices in significant pessimism, but historical resilience may offer patient investors a favorable entry.